一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (495k)
Article in Japanese

Case Report

A case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy

Kazutoshi Isobe1)  Sei Muraoka1)  Keishi Sugino1)  Yoko Yamazaki1)  Naoshi Kikuchi1)  Nobuyuki Hamanaka1)  Yujiro Takai1)  Kunihiko Shimizu1)  Kazuhiro Kimura1)  Naoki Hiroi3)  Kazutoshi Shibuya2)  Sakae Homma1) 

1)Department of Respiratory Medicine 2)Department of Pathology 3)Department of Diabetes, Metabolism and Endocrinology Medicine, Toho University Omori Medical Center

ABSTRACT

A 75-year-old man presented with hemoptysis. Consolidation was identified in the left lower lobe around multiple bullae. He was found to have chronic necrotizing pulmonary aspergillosis based on a high titer of aspergillus antigen and positive antibody. He was treated with 400 mg/day voriconazole. However, liver dysfunction and hyponatremia developed at 21 days after beginning administration of voriconazole. Serum sodium levels were 122 mEq/l. but urinary sodium showed a high level of 135 mEq/l. The serum sodium level improved 10 days after voriconazole was discontinued. Serum levels of voriconazole on day 15 were high at 18 μg/ml (safe effective serum level: 1.5 to 4.5 μg/ml). An analysis of genetic polymorphism showed a mutation of cytochrome P450 (CYP2C19*2G681A). We report the first case of a voriconazole-induced syndrome of inappropriate antidiuretic hormone caused by a polymorphism mutation of cytochrome P450.

KEYWORDS

Pulmonary aspergillosis  Chronic necrotizing pulmonary aspergillosis  Voriconazole  Syndrome of inappropriate antidiuretic hormone  Genetic polymorphism 

Received 平成18年11月8日

JJRS, 45(6): 489-493, 2007

Google Scholar